SimCorp to transform private market investing with SimCorp Alternatives
Highlights: SimCorp launches SimCorp Alternatives, a comprehensive offering designed to serve the…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at…
SimCorp names Peter Sanderson as Chief Executive Officer
Sanderson has proven track record of driving growth and deep industry knowledge Sanderson…
Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tbingen
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the…
Comviva Accelerates AI-First Transformation and SaaSification with AWS to Power Next-Gen Digital Solutions
AWS to fuel advanced Generative AI use cases across a diverse suite…
Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Introducing FactsR by Corti — the First Clinical Reasoning Layer for Ambient AI in Healthcare
Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and…
cBrain appoints new CFO
Company Announcement no. 07/2025 cBrain appoints new CFO Copenhagen, June 11, 2025…